ICICI Prudential US Bluechip Equity Fund - Growth
Category: Equity: Thematic-International
Launch Date: 01-07-2012
AUM:
₹ 3,112.72 Cr
Expense Ratio
2.02%
Benchmark
S&P 500 TRI
ISIN
INF109K01E35
Minimum Investment
5000.0
Minimum Topup
1000.0
Minimum SIP Amount
100
Fund Manager
Ritesh Lunawat
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| ICICI Prudential US Bluechip Equity Fund - Growth | 9.56 | 13.37 | 13.64 |
| Benchmark | - | - | - |
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
Overview
NAV
64.29
Last change
-0.22 (-0.3422%)
Fund Size (AUM)
₹ 3,112.72 Cr
Performance
15.21% (Inception)
Asset Allocation
Equity
Debt
Others
Nav Movement
Investment Objective
The investment objective of ICICI Prudential US Bluechip Equity Fund is to provide long term capital appreciation to investors by primarily investing in equity and equity related securities of companies listed on recognized stock exchanges in the United States of America. The Scheme shall also invest in ADRs/GDRs issued by Indian and foreign companies. However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved.
Fund Manager
Ritesh Lunawat
Riskometer
Very High
Top 10 Holdings
| Company | Holdings (%) |
|---|---|
| West Pharmaceutical Services Inc | 2.83 |
| Huntington Ingalls Industries Inc | 2.81 |
| Monolithic Power Systems Inc | 2.59 |
| Estee Lauder Cos Inc | 2.56 |
| Nike Inc | 2.53 |
| GE HealthCare Technologies Inc | 2.45 |
| Pfizer Inc | 2.42 |
| Allegion plc | 2.42 |
| US Bancorp Inc | 2.41 |
| Zimmer Biomet Holdings Inc | 2.36 |
Sector Allocation
| Sector | Holdings (%) |
|---|
Peer Comparison
| Scheme Name | 5Y (%) |
|---|---|
| ICICI Pru US Bluechip Equity Gr | 13.64 |
| ABSL Intl Equity Gr Reg | 11.3 |
| Nippon India US Equity Opportunities Fund Gr Gr | 12.86 |
| Franklin Asian Equity Gr | 3.78 |
| Nippon India Japan Equity Gr Gr | 7.56 |